Triangle Pharma

Acquired

Home - Alcami

Durham, United States · Founded 1995

Founded
1995
Business Model
B2B
Rounds
1
Acquired by
GileadDec 2002

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Triangle Pharmaceuticals, Inc. was a specialty pharmaceutical company engaged in developing new antiviral drug candidates, with a particular focus on therapies for HIV and hepatitis B. Its proprietary pipeline included Coviracil (emtricitabine), amdoxovir, and clevudine. Headquartered in Durham, North Carolina, the company was acquired by Gilead Sciences in a $464 million transaction announced in December 2002, strengthening Gilead's antiviral franchise.

Summary

Triangle Pharma is a Biotech company based in Durham, United States, founded in 1995. Investors include Domain Associates, SV Health Investors and Venrock.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionDec 2002

Sign up to see all 2 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech, Artificial Intelligence
Series ETotal funding$1.1BSep 2026
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$821.8MSep 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Triangle Pharma on Indexed.vc
<a href="https://indexed.vc/companies/triangle-pharma"><img src="https://indexed.vc/api/badge/company/triangle-pharma" alt="Triangle Pharma on Indexed.vc" width="260" height="76" /></a>